4American Gastroenterological Association.American Gastroenterological Association medical position statement:Evaluation of dyspepsia.Gastroenterology,2005,129 (5):1756-1780.
5Chinese Society of gastroenterology,Chinese Medical Association.Consensus on the management of Helicobacter pylori infection:Tongcheng,Anhui Province,2003.Chin J Dig Dis,2004,5 (4):186-188.
6Gisbert JP,Calvet X,Gomollon F,et al.Eradication treatment of Helicobacter pylori.Recommendations of theⅡ Spanish Consensus Conference.Med Clin (Barc),2005,125 (8):301-316.
7Megraud F.H pylori antibiotic resistance:prevalence,importance,and advances in testing.Gut,2004,53 (9):1374-1384.
8Moayyedi P,Hunt RH.Helicobacter pylori public health implications.Helicobacter,2004,9 Suppl 1:67-72.
9Moayyedi P,Soo S,Deeks J,et al.Eradication of Helicobacter pylori for non-ulcer dyspepsia.Cochrane Database Syst Rev,2006,19 (2):CD002096.
10Ruggiero P,Peppoloni S,Rappuoli R,et al.The quest for a vaccine against Helicobacter pylori:how to move from mouse to man? Microbes Infect,2003,5 (8):749-756.
2Kim RH, Chang MS, Kim HI, et al. Medical history and lifestyle factors contributing to Epstein Barr virus associated gastric carcino- ma and conventional gastric carcinoma in Korea [J]. Anticancer Rcs, 2010, 30(6): 2469-2475.
3Niccoli G, Franceschi F, Cosentino N, et al. Coronary atherosclerot- ic burden in patients with infection by CagA positive strains of Heli- cobacter pflori [J]. Coron Artery Dis, 2010, 21 (4): 217-221.
4Luther J, Dave M, Higgins PD, et al. Association between Helico- bacter pylori infection and inflammatory bowel disease: a meta-anal- ysis and systematic review of the literature [J]. Inflamm Bowel Dis, 2010, 16(6): 1077-1084.
5Carrasco G, Diaz J, Valbuena JR, et al. Overexpression of p73 as a tissue marker for high-risk gastritis [J]. Clin Cancer Res, 2010, 16 (12): 3253-3259.
6Makhmudov MG. Application of low-intensive laser irradiation in the treatment of perforative gastroduodenal ulcers [J]. Klin Khir, 2010, 5: 15-17.
